317 results
Page 3 of 16
8-K
EX-99.1
ul9jocgmmmc0
25 Feb 21
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:07pm
424B5
9qcgz ls3qwr
16 Feb 21
Prospectus supplement for primary offering
4:49pm
424B5
8m5qsmauxp
16 Feb 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-4.1
8pwz 8erzeqrtz6g
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.2
seiy2qnockwou8s
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-10.1
rra4kbzgr5dk4d jyl7o
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
8-K
EX-99.1
poh0b
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
8-K
EX-99.1
hbf5vt dort
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
8-K
EX-10.2
afvd 3frgvceo
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
czoag9sqawd6cz
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-4.1
xxbk96 c7
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
tvf35koxc99tvkl8op3y
29 Jun 20
Prospectus supplement
12:00am
424B5
du3ru
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
p7uyntn9
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-4.1
3uogd2dom2zt63kucw
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-99.1
moxit6gubkuq4385r
7 May 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results
4:09pm